In this issue, Thomas Kupper and colleagues report that mice deficient for ROR-γ or interleukin-23 (IL-23) receptor showed impaired melanoma growth. Tumor growth inhibition was dependent in part on IL-9 and T helper type 9 (TH9) cells. Moreover, the authors showed that IL-9 acts on mast cells rather than T or B cells to mediate its antitumor effects and that TH9 cells are present in human blood and skin, suggesting that a role for TH9 cells in human tumor immunity should be explored.
- Rahul Purwar
- Christoph Schlapbach
- Thomas S Kupper